| abstract |
The present invention relates to a general formula (1): [Each symbol in the formula is as defined in the specification. ] The cyanotriazole compound represented by these, or its salt. The compound or a salt thereof has few side effects and is excellent in safety, enhances citric acid cycle activity and / or improves hyperglycemia. Accordingly, diseases or disorders in which citrate cycle activation and / or improvement of hyperglycemia have a preventive and / or therapeutic effect (eg, diabetes, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, dyslipidemia) , Fatty liver, atherosclerosis and / or cardiovascular disease, and diseases or disorders that benefit from accelerated energy consumption). |